Neuroimaging Helps Differentiate Dementia from Depression
By MedImaging International staff writers Posted on 10 Mar 2017 |
Image: Representative brain SPECT scans in Alzheimer\'s dementia and depression (Photo courtesy of Amen Clinics).
A new study suggests that single photon emission computed tomography (SPECT) can help doctors discriminate between depression and cognitive disorders (CDs).
Researchers at Amen Clinics, the University of California, San Francisco, and other institutions conducted a study involving 4,541 patients to evaluate if perfusion neuroimaging with brain SPECT can distinguish between persons with depression from those with CDs (Alzheimer’s disease, vascular dementia, dementia not otherwise specified, and amnestic disorders not otherwise specified), or both conditions.
Of the patients in the study, 847 were diagnosed with a CD, 3,269 were diagnosed with depression, and 425 suffered from both conditions. Using brain SPECT imaging, the researchers calculated perfusion differences between groups, using two-sampled t-tests corrected for multiple comparisons. Diagnostic separation was then determined with discriminant analysis, revealing predictive regions that could help delineate depression from CDs and comorbid cases. For example, the researchers found that people with CDs had lower cerebral perfusion in multiple areas compared to those with depression, particularly in the hippocampus, temporal, and parietal lobes.
In co-morbid persons, on the other hand, cerebral hypoperfusion was additive, showing lower regional cerebral blood flow compared to either diagnosis alone. They also found that SPECT could distinguish depression from CDs with 86% accuracy, and that brain SPECT imaging showed the ability to distinguish depression or dementia in people with both conditions with 83% accuracy. Feature selection identified the most predictive regions, which were the left hippocampus, right insula, cerebellar, and frontal lobe regions. The study was published on February 10, 2017, in Journal of Alzheimer's Disease.
“Cognitive impairment is present in approximately half of persons who have late onset depression, and depression is evident in 9-65% of individuals with dementia,” concluded lead author psychiatrist Daniel Amen, MD. “It is often challenging to diagnostically disentangle depression and cognitive disorders from one another. These disorders have very different prognoses and treatments, and being able to improve diagnostic accuracy can improve outcomes for some patients.”
Researchers at Amen Clinics, the University of California, San Francisco, and other institutions conducted a study involving 4,541 patients to evaluate if perfusion neuroimaging with brain SPECT can distinguish between persons with depression from those with CDs (Alzheimer’s disease, vascular dementia, dementia not otherwise specified, and amnestic disorders not otherwise specified), or both conditions.
Of the patients in the study, 847 were diagnosed with a CD, 3,269 were diagnosed with depression, and 425 suffered from both conditions. Using brain SPECT imaging, the researchers calculated perfusion differences between groups, using two-sampled t-tests corrected for multiple comparisons. Diagnostic separation was then determined with discriminant analysis, revealing predictive regions that could help delineate depression from CDs and comorbid cases. For example, the researchers found that people with CDs had lower cerebral perfusion in multiple areas compared to those with depression, particularly in the hippocampus, temporal, and parietal lobes.
In co-morbid persons, on the other hand, cerebral hypoperfusion was additive, showing lower regional cerebral blood flow compared to either diagnosis alone. They also found that SPECT could distinguish depression from CDs with 86% accuracy, and that brain SPECT imaging showed the ability to distinguish depression or dementia in people with both conditions with 83% accuracy. Feature selection identified the most predictive regions, which were the left hippocampus, right insula, cerebellar, and frontal lobe regions. The study was published on February 10, 2017, in Journal of Alzheimer's Disease.
“Cognitive impairment is present in approximately half of persons who have late onset depression, and depression is evident in 9-65% of individuals with dementia,” concluded lead author psychiatrist Daniel Amen, MD. “It is often challenging to diagnostically disentangle depression and cognitive disorders from one another. These disorders have very different prognoses and treatments, and being able to improve diagnostic accuracy can improve outcomes for some patients.”
Latest General/Advanced Imaging News
- Radiation Therapy Computed Tomography Solution Boosts Imaging Accuracy
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging
- State-Of-The-Art System Enhances Accuracy of Image-Guided Diagnostic and Interventional Procedures
- Catheter-Based Device with New Cardiovascular Imaging Approach Offers Unprecedented View of Dangerous Plaques